BioCryst signs agreement with Er-Kim Pharmaceuticals to commercialise ORLADEYO in Turkey

One capsule of ORLADEYO a day helps to prevent HAE attacks by reducing the activity of plasma kallikrein. Credit: Anemone123 from Pixabay.